D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia

NCT00237809 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: D-serine
BEHAVIORAL: Cognitive Retraining (CRT)
DRUG: Placebo
BEHAVIORAL: Cognitive Retraining Placebo

Sponsor

Yale University

Collaborators

[object Object]
[object Object]